sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings

$641,004

Saad B. Omer · Ut Southwestern Medical Center · R01 · FY2024 · AI

Pragmatic RCT of a multi-level mechanistically informed community intervention to prevent the onset of behavioral health symptoms among socioeconomically disadvantaged pandemic affected children

$640,862

Tara Leytham-Powell · University Of Illinois At Urbana-Champaign · R01 · FY2023 · MH

Mechanisms of CD8 TRM-mediated protection against respiratory virus transmission

$640,735

Jacob E Kohlmeier · Emory University · R56 · FY2024 · AI

Expanding Excellence in Developmental Biology in Oklahoma Supplement: 3D Human Lung Tissue Model to Dissect Cellular Responses upon SARS-CoV-2 Infection

$640,692

Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2023 · GM

Defining mucosal plasma cell origin, residence, and longevity in the upper airway

$640,221

E. Ashley Moseman · Duke University · R01 · FY2025 · AI

An Intrinsic Link between the Metabolic and Antiviral States of the Cell

$639,828

Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

CD38, T cells and post viral lung sequelae during aging

$639,740

Jie Sun · University Of Virginia · R01 · FY2025 · AG

Mechanisms underlying COVID-19 induced Neurocognitive Dysfunction

$639,692

Paul E Schulz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG

Mechanisms underlying COVID-19 induced Neurocognitive Dysfunction

$639,561

Paul E Schulz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · AG

COVID-19 Structural Vaccinology

$639,365

Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Behavioral and Social Science Research to Optimize SARS-CoV-2 Protective Vaccine Uptake in Racial Minority Communities with High Rates of COVID-19

$639,327

Jeffrey A. Kelly · Medical College Of Wisconsin · R01 · FY2021 · MD

Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses

$639,235

Ann R Falsey · University Of Rochester · R01 · FY2021 · AI

Reaching Communities through the Design of Information Visualizations (ReDIVis) Toolbox for Return of COVID-19 Results

$639,012

Suzanne Bakken · Columbia University Health Sciences · P30 · FY2021 · NR

Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention

$638,992

Steve W Cole · University Of California Los Angeles · R01 · FY2022 · AG

Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy

$638,887

Gulin Oz · University Of Minnesota · R01 · FY2023 · NS

Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches

$638,826

Roberto Aiolfi · Scripps Research Institute, The · R01 · FY2025 · HL

Development and characterization of engineered therapeutic antibodies against SARS-CoV-2

$638,713

Gaya K. Amarasinghe · Washington University · R01 · FY2023 · AI

Antibody Engineering Program

$638,442

Mitchell Ho · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

Cerebral Energy Metabolism in ME/CFS with and without PASC

$638,237

Xiang Xu · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS

TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung

$638,230

Ya-Wen Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL

SARS-CoV-2 in Correctional Populations: A collaborative, ethical approach to application of wastewater-based surveillance

$638,186

Anne C Spaulding · Emory University · U01 · FY2023 · DA

Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex

$638,072

Seth A Darst · Rockefeller University · R01 · FY2021 · AI

Immunoengineering

Targeting SARS-CoV-2 PLpro for COVID-19 treatment

Insights into Sickle Cell Trait and Sickle Cell Disease

COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings

Pragmatic RCT of a multi-level mechanistically informed community intervention to prevent the onset of behavioral health symptoms among socioeconomically disadvantaged pandemic affected children

Mechanisms of CD8 TRM-mediated protection against respiratory virus transmission

Expanding Excellence in Developmental Biology in Oklahoma Supplement: 3D Human Lung Tissue Model to Dissect Cellular Responses upon SARS-CoV-2 Infection

Defining mucosal plasma cell origin, residence, and longevity in the upper airway

An Intrinsic Link between the Metabolic and Antiviral States of the Cell

CD38, T cells and post viral lung sequelae during aging

Mechanisms underlying COVID-19 induced Neurocognitive Dysfunction

Mechanisms underlying COVID-19 induced Neurocognitive Dysfunction

COVID-19 Structural Vaccinology

Behavioral and Social Science Research to Optimize SARS-CoV-2 Protective Vaccine Uptake in Racial Minority Communities with High Rates of COVID-19

Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses

Reaching Communities through the Design of Information Visualizations (ReDIVis) Toolbox for Return of COVID-19 Results

Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention

Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy

Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches

Development and characterization of engineered therapeutic antibodies against SARS-CoV-2

Antibody Engineering Program

Cerebral Energy Metabolism in ME/CFS with and without PASC

TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung

SARS-CoV-2 in Correctional Populations: A collaborative, ethical approach to application of wastewater-based surveillance

Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex